Suppr超能文献

工程抗生素抗癌:优化新生霉素骨架产生抗增殖剂。

Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents.

机构信息

Department of Medicinal Chemistry, The University of Kansas, Lawrence, KS 66045-7563, USA.

出版信息

J Med Chem. 2011 Jun 9;54(11):3839-53. doi: 10.1021/jm200148p. Epub 2011 May 9.

Abstract

Development of the DNA gyrase inhibitor, novobiocin, into a selective Hsp90 inhibitor was accomplished through structural modifications to the amide side chain, coumarin ring, and sugar moiety. These species exhibit ∼700-fold improved anti-proliferative activity versus the natural product as evaluated by cellular efficacies against breast, colon, prostate, lung, and other cancer cell lines. Utilization of structure-activity relationships established for three novobiocin synthons produced optimized scaffolds, which manifest midnanomolar activity against a panel of cancer cell lines and serve as lead compounds that manifest their activities through Hsp90 inhibition.

摘要

通过对酰胺侧链、香豆素环和糖部分的结构修饰,将 DNA 拓扑异构酶抑制剂新生霉素开发成选择性 Hsp90 抑制剂。这些化合物在细胞效价方面对乳腺癌、结肠癌、前列腺癌、肺癌和其他癌细胞系的增殖活性比天然产物提高了约 700 倍。利用为三种新生霉素合成子建立的构效关系,产生了优化的支架,这些支架对一系列癌细胞系表现出中纳摩尔的活性,并作为先导化合物,通过 Hsp90 抑制发挥其活性。

相似文献

6
Novobiocin Analogues That Inhibit the MAPK Pathway.抑制丝裂原活化蛋白激酶(MAPK)信号通路的新生霉素类似物
J Med Chem. 2016 Feb 11;59(3):925-33. doi: 10.1021/acs.jmedchem.5b01354. Epub 2016 Jan 27.
7
Novobiocin Analogs as Potential Anticancer Agents.新霉素类似物作为潜在的抗癌剂。
Mini Rev Med Chem. 2017;17(9):728-733. doi: 10.2174/1389557516666161223155525.

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验